Latest Breaking News On - Dominick angiolillo - Page 1 : comparemela.com

Avoid Using Prasugrel With Cangrelor During PCI, SWAP-6 Affirms

The findings support current drug labeling, which says prasugrel should be given at the end of the cangrelor infusion.

Noord hollandFrancesco franchiMattia galliDominick angiolilloEuropean medicines agencyMd university of florida college medicineDrug administrationPhd university of florida college medicineEuropean society of cardiology congressFlorida collegeCardiovascular interventionsMaria cecilia hospitalEuropean societyCardiology congress

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions
tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.

Dominick angiolilloDavide capodannoAcademic research consortiumPhd university of cataniaDevices agencyDrug administrationPhd university of florida college medicineJapanese pharmaceuticalsFlorida collegeMedical devices

Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5

The study found potent platelet inhibition and no drug-drug interactions, but hard outcome studies are needed, experts say.

United statesJennifer rymerLuis ortega pazFrancesco franchiGiuseppe gargiuloDominick angiolilloAmerican heart associationMd university of florida college medicineMd duke university medical centerPhd university of florida college medicineDrug administrationPhd university federicoFlorida collegeDuke university medical centerCardiovascular interventionsSwitching antiplatelet

Managing AF Patients Undergoing PCI—Some Lingering Questions

The field has more data, but cardiologists still face challenges in deciding when to drop aspirin and what anticoagulant to use.

United statesFrance generalGilles montalescotShaun goodmanChristopher grangerDominick angiolilloAmerican college of cardiologyPhd university of florida college medicineBristol myers squibbPhd centre hospitalier universitaire pitiAmerican college of cardiology heart associationMd duke clinical research instituteMd university of toronto stAmerican collegeCentre hospitalier universitaire pitiNorth american

Observational Study Supports Continuing Oral Anticoagulation During PCI

April 06, 2021 For patients sent for an unplanned PCI, a strategy of maintaining oral anticoagulation is not associated with a higher risk of ischemic complications or bleeding when compared with a strategy of interrupting the direct oral anticoagulant (DOAC) or vitamin K antagonist (VKA) a day or two before the procedure, a new observational analysis confirms. Published in the April 12, 2021, issue of JACC: Cardiovascular Interventions, the study, drawing on the large SWEDEHEART registry, supports the current recommendations from the European Society of Cardiology (ESC) for uninterrupted oral anticoagulation (U-OAC) in patients with atrial fibrillation, venous thromboembolism, or a mechanical heart valve undergoing unplanned, nonemergent PCI, investigators say.

United statesDimitrios venetsanosDharam kumbhaniPiera capranzanoSanjit jollyBayer janssenBristol myers squibbDominick angiolilloPhd university of cataniaMd ut southwestern medical centerAmerican college of cardiologyMd mcmaster university hamilton health sciencesBoehringer ingelheimPhd karolinska institute university hospitalPhd university of florida college medicineEuropean society of cardiology